NCT06776159 The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
| NCT ID | NCT06776159 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | CVD - Cardiovascular Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2025-06-24 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2025-06-24 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Eligibility Criteria
Inclusion Criteria: * patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day * Chinese Exclusion Criteria: * cognitively impaired * unconscious * refuse to participate
Contact & Investigator
Arkers Wong
PRINCIPAL INVESTIGATOR
The Hong Kong Polytechnic University
Frequently Asked Questions
Who can join the NCT06776159 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying CVD - Cardiovascular Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06776159 currently recruiting?
Yes, NCT06776159 is actively recruiting participants. Contact the research team at frankie.py.cheung@polyu.edu.hk for enrollment information.
Where is the NCT06776159 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT06776159 clinical trial?
NCT06776159 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Arkers Wong at The Hong Kong Polytechnic University. The trial plans to enroll 180 participants.